Zealand Pharma raises $1 billion in equity offering



Zealand Pharma A/S completed an upsized equity offering on 26 June with the placement of 8.35 million shares with investors raising gross proceeds of DKK 7 billion ($1 billion). This will enable it to finance its prospective peptide-based medicines for obesity and metabolic and rare diseases well into the future. The directed share issue and private placement exceeded the initial targeted amount by $100 million.